Dementia Mental and Behavioural Disorders Unspecified dementia
Conditions
Interventions
1. Intervention arm: participants in the experimental arm (i.e. all residents in homes randomised to receive the intervention) will be cared for under a regime in which care staff have:
Sponsors
Humber Teaching NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Identification of homes (clusters): Within the trial area, an invitation to participate in the trial will be sent to all care homes with 25+ beds listed on the website of the Care Quality Commission (CQC) as old age care homes, with a rating of 'good' or 'excellent', (a) with nursing care and (b) without nursing care. Homes specialising in care of residents with dementia will not be excluded. 2. Consent of care home residents
Exclusion criteria
Exclusion criteria: 1. Residents whose stay in the home is not, in the judgement of the home manager, likely to be for long term care - for example those receiving respite care 2. Residents who are in the palliative stages of a disease at the time of recruitment 3. Residents who are unable to speak/understand English 4. Residents who enter the home part way through the study or who are out of the home (for example in hospital) at the time of data collection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuropsychiatric Inventory with Caregiver Distress Scale (NPI-D) This is a validated measure based on informant interview and designed to rate frequency, severity and caregiver distress for 12 Challenging Behaviour categories - delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, elation/euphoria, apathy/indifference, disinhibition, irritability/lability, aberrant motor behaviour, sleep, appetite/eating disorders. The primary research question will be addressed by analysis of the frequency and severity scores. Outcome will be measured at baseline, 4 months and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures as of 24/02/2016: 1. Staff and resident quality of life is measured using the Euroqol-5D (EQ-5D) 2. Resident quality of life is measured using the Quality of Life in Alzheimer's Disease (QOL-AD) 3. Diagnostic criteria for dementia is measured using the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) 4. Frequency and severity of challenging behaviour in residents is measured using the Challenging Behaviour Scale (CBS) 5. Attitudes of staff towards people with dementia is measured using the Attitudes to Dementia Questionnaire (ADQ) 6. Perceived effectiveness of staff in caring for people with dementia is measured using the Self-Efficacy Scale 7. Resident health and social care resource use is measured using the (Adapted) Client Service Receipt Inventory (CSRI) 8. Resident medication use is measured using the Structured Medication Inventory (SMI) 9. Clinical Dementia Rating (CDR) is used as a covariate for analysis 10. Emotional impact of, or reaction to, challenging behaviour is measured using the Maslach Burnout Inventory (MBI) and the NPI caregiver distress score 11. Frequency and severity of challenging behaviour in residents is measured using the Cohen-Mansfield Agitation Inventory (CMAI) 12. Staff learning style is measured using the Visual Auditory Kinesthetic (VAK) Learning Styles Self-Assessment Questionnaire All outcomes will be measured at baseline, 4 months and 12 months Original secondary outcome measures: 1. Euroqol-5D (EQ-5D) 2. Quality of Life in Alzheimer's Disease (QOL-AD) 3. Short Form 12 (SF-12) 4. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) 5. Challenging Behavi | — |
Countries
England, United Kingdom
Outcome results
None listed